These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Hypothalamic growth hormone-releasing hormone (GHRH) cell number is increased in human illness, but is not reduced in Prader-Willi syndrome or obesity. Goldstone AP; Unmehopa UA; Swaab DF Clin Endocrinol (Oxf); 2003 Jun; 58(6):743-55. PubMed ID: 12780752 [TBL] [Abstract][Full Text] [Related]
3. Endocrine disorders in Prader-Willi syndrome: a model to understand and treat hypothalamic dysfunction. Tauber M; Hoybye C Lancet Diabetes Endocrinol; 2021 Apr; 9(4):235-246. PubMed ID: 33647242 [TBL] [Abstract][Full Text] [Related]
4. The Prader-Willi syndrome: a study of 40 patients and a review of the literature. Bray GA; Dahms WT; Swerdloff RS; Fiser RH; Atkinson RL; Carrel RE Medicine (Baltimore); 1983 Mar; 62(2):59-80. PubMed ID: 6338343 [TBL] [Abstract][Full Text] [Related]
5. Neuropeptides in hypothalamic neuronal disorders. Swaab DF Int Rev Cytol; 2004; 240():305-75. PubMed ID: 15548416 [TBL] [Abstract][Full Text] [Related]
6. Central precocious puberty in a girl with Prader-Willi syndrome. Lee HS; Hwang JS J Pediatr Endocrinol Metab; 2013; 26(11-12):1201-4. PubMed ID: 23740678 [TBL] [Abstract][Full Text] [Related]
7. Somatropin therapy for children with prader-willi syndrome : guidelines for use. Lindgren AC Treat Endocrinol; 2006; 5(4):223-8. PubMed ID: 16879001 [TBL] [Abstract][Full Text] [Related]
8. Endocrine dysfunction in Prader-Willi syndrome: a review with special reference to GH. Burman P; Ritzén EM; Lindgren AC Endocr Rev; 2001 Dec; 22(6):787-99. PubMed ID: 11739333 [TBL] [Abstract][Full Text] [Related]
9. Alterations in the hypothalamic paraventricular nucleus and its oxytocin neurons (putative satiety cells) in Prader-Willi syndrome: a study of five cases. Swaab DF; Purba JS; Hofman MA J Clin Endocrinol Metab; 1995 Feb; 80(2):573-9. PubMed ID: 7852523 [TBL] [Abstract][Full Text] [Related]
11. Disruption of the mouse Necdin gene results in hypothalamic and behavioral alterations reminiscent of the human Prader-Willi syndrome. Muscatelli F; Abrous DN; Massacrier A; Boccaccio I; Le Moal M; Cau P; Cremer H Hum Mol Genet; 2000 Dec; 9(20):3101-10. PubMed ID: 11115855 [TBL] [Abstract][Full Text] [Related]
12. Leptin concentrations in Prader-Willi syndrome before and after growth hormone replacement. Myers SE; Davis A; Whitman BY; Santiago JV; Landt M Clin Endocrinol (Oxf); 2000 Jan; 52(1):101-5. PubMed ID: 10651760 [TBL] [Abstract][Full Text] [Related]
13. Brown SSG; Manning KE; Fletcher P; Holland A Brain Commun; 2022; 4(5):fcac229. PubMed ID: 36147452 [TBL] [Abstract][Full Text] [Related]
15. Linear growth response to exogenous growth hormone in Prader-Willi syndrome. Lee PD; Wilson DM; Rountree L; Hintz RL; Rosenfeld RG Am J Med Genet; 1987 Dec; 28(4):865-71. PubMed ID: 3688024 [TBL] [Abstract][Full Text] [Related]
17. Disorders of hypothalamic function: Insights from Prader-Willi syndrome and the effects of craniopharyngioma. Whittington JE; Holland AJ Handb Clin Neurol; 2021; 181():381-389. PubMed ID: 34238472 [TBL] [Abstract][Full Text] [Related]
18. Pubertal development in the Prader-Labhart-Willi syndrome. Kauli R; Prager-Lewin R; Laron Z Acta Paediatr Scand; 1978 Nov; 67(6):763-7. PubMed ID: 362802 [TBL] [Abstract][Full Text] [Related]
19. [Endocrinological study on Prader-Willi syndrome: report of four cases and review of literature (author's transl)]. Ohashi T; Takeda K; Morioka M; Akaeda T; Kumon H; Mitsuhata N; Ohmori H; Higuchi J Nihon Hinyokika Gakkai Zasshi; 1980 Sep; 71(9):999-1009. PubMed ID: 6780715 [No Abstract] [Full Text] [Related]
20. The Prader-Willi syndrome: neuroendocrine study of identical twins. Trevisan C; Saia A; Schergna E; Mantero F Ital J Neurol Sci; 1983 Apr; 4(1):79-83. PubMed ID: 6683267 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]